Incyclinide

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameIncyclinide
Drug Alias Name英环奈德inciclinidaincyclinidumMetastatNSC-683551 +[7
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of ActionMatrix metalloproteinase 9 inhibitorsMatrix metalloproteinase-2 inhibitors
TargetsMatrix metalloproteinase 9Matrix metalloproteinase-2
Therapy Area/IndicationsCNS Embryonal TumorSolid tumoursRosacea +[10
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGalderma Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCNS Embryonal TumorSolid tumoursRosacea +[10

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG